Impact of abciximab on coronary restenosis in diabetic patients undergoing elective paclitaxel-eluting stent implantation. A prospective, randomized, placebo-controlled study. [electronic resource]
Producer: 20081104Description: 93-9 p. digitalISSN:- 1748-2941
- Abciximab
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Coated Materials, Biocompatible
- Coronary Angiography
- Coronary Restenosis -- complications
- Diabetes Complications -- blood
- Double-Blind Method
- Elective Surgical Procedures -- methods
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Male
- Middle Aged
- Myocardial Revascularization -- instrumentation
- Paclitaxel -- therapeutic use
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Prospective Studies
- Stents
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.